Search
Search Results
##search.searchResults.foundPlural##
-
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2074PDF: 838HTML: 300 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
788PDF: 523HTML: 4003 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1982PDF: 1599HTML: 345 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2736PDF: 899HTML: 7299 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4332PDF: 1868HTML: 17709 -
IMPLEMENTATION OF MICROELIMINATION STRATEGY IN ERADICATION OF CHRONIC HEPATITIS C INFECTION IN PATIENTS WITH HEMOPHILIA IN THE NORTHERN REGION OF SERBIA Microelimination Strategy of Chronic Hepatitis C Infection in patients with Hemophilia
801PDF: 310HTML: 138 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1259PDF: 1086HTML: 93 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1865PDF: 1052HTML: 565 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3130PDF: 1021HTML: 412 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3519PDF: 1080HTML: 23315 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2204PDF: 1293HTML: 17058Bassan Fig.1: 133Bassan Fig.2: 129Bassan Fig.4: 126Fig.3: 164 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
1997PDF: 910HTML: 126Suppl. Files: 491 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1454PDF: 470HTML: 203 -
-
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1182PDF: 699HTML: 290 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1618PDF: 1059HTML: 10688Untitled: 163 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2545PDF: 1046HTML: 99 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2367PDF: 1250HTML: 1718CoverLetter: 159 -
-
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
1862PDF: 1059HTML: 1884Lung computed tomography CT scan image: 183 -
DETECTION OF OCCULT GLOMERULAR DYSFUNCTION IN GLUCOSE SIX PHOSPHATE DEHYDROGENASE DEFICIENCY ANEMIA
3649PDF: 1194HTML: 1691Untitled: 144 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1327PDF: 656HTML: 1067Untitled: 165Untitled: 130Untitled: 114Untitled: 137Untitled: 143 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1446PDF: 690HTML: 214 -
Sickle cell disease and Bartonella spp. infection
1108PDF: 835HTML: 442 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
890PDF: 558HTML: 2177Cover Letter: 174 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3033PDF: 1110HTML: 369 -
IRON DEFICIENCY ANAEMIA AMONG PRE-SCHOOL CHILDREN WITH SICKLE CELL ANAEMIA: STILL A RARE DIAGNOSIS?
1268PDF: 795HTML: 2875cover leer: 131 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1752HTML: 1361PDF: 1025 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1321PDF: 1270HTML: 79 -
-
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4010PDF: 1196HTML: 1944Table 1: 175







